These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7845674)

  • 21. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex.
    Kim H; Lee JE; Cho EJ; Liu JO; Youn HD
    Cancer Res; 2003 Oct; 63(19):6135-9. PubMed ID: 14559791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and distribution of AP-1 transcription factors in the porcine ovary.
    Rusovici R; LaVoie HA
    Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
    Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
    Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
    Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
    Bost F; Caron L; Vial E; Montreau N; Marchetti I; Dejong V; Defize L; Castellazzi M; Binétruy B
    Oncogene; 2001 Nov; 20(50):7425-9. PubMed ID: 11704873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets.
    Leaner VD; Kinoshita I; Birrer MJ
    Oncogene; 2003 Aug; 22(36):5619-29. PubMed ID: 12944910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
    Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A
    Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S; Vial E; van Dam H; Castellazzi M
    Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.
    Westermarck J; Lohi J; Keski-Oja J; Kähäri VM
    Cell Growth Differ; 1994 Nov; 5(11):1205-13. PubMed ID: 7848922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
    Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.
    Kameda T; Akahori A; Sonobe MH; Suzuki T; Endo T; Iba H
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9369-73. PubMed ID: 8415709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chicken junD gene and its product.
    Hartl M; Hutchins JT; Vogt PK
    Oncogene; 1991 Sep; 6(9):1623-31. PubMed ID: 1923529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S; Brown PH; Birrer MJ
    Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E; Perez S; Castellazzi M
    Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
    Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
    Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization.
    Vandel L; Montreau N; Vial E; Pfarr CM; Binetruy B; Castellazzi M
    Mol Cell Biol; 1996 May; 16(5):1881-8. PubMed ID: 8628254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.